The Community Guide

- gsearch

Search Results

Narrow Results:

2024 8
2023 3
2021 2

Japan 10

Journal Article 13

1 - 13 of 13 Results

Refine Results

Refine Results:

Risk of cancer associated with low‑dose radiation exposure: comparison of results between the INWORKS nuclear workers study and the A‑bomb survivors study

CITE Title : Risk of cancer associated with low‑dose radiation exposure: comparison of results between the INWORKS nuclear workers study and the A‑bomb survivors study Personal Author(s) : Leuraud, Klervi;Richardson, David B.;Cardis, Elisabeth;Daniels, Robert D.;Gillies, Michael;Haylock, Richard;Moissonnier, Monika;Schubauer‑Berigan, Mary K.;Thierry‑Chef, Isabelle;Kesminiene, Ausrele;Laurier, Dominique; Published Date : 2021;3-2021; Source : Radiat Environ Biophys. 60(1):23-39 URL : https://stacks.cdc.gov/view/cdc/103801 Leuraud, Klervi et al. (2021). Risk of cancer associated with low‑dose radiation exposure: comparison of results between the INWORKS nuclear workers study and the A‑bomb survivors study. 60(1). Leuraud, Klervi et al. "Risk of cancer associated with low‑dose radiation exposure: comparison of results between the INWORKS nuclear workers study and the A‑bomb survivors study" 60, no. 1 (2021) Leuraud, Klervi et al. "Risk of cancer associated with low‑dose radiation exposure: comparison of results between the INWORKS nuclear workers study and the A‑bomb survivors study" vol. 60, no. 1, 2021 Export RIS Citation Information.

:

Leuraud, Klervi

;

Richardson, David B.

2021 | Radiat Environ Biophys. 60(1):23-39

:

The Life Span Study (LSS) of Japanese atomic bomb survivors has served as the primary basis for estimates of radiation-related disease risks that info...
Prevalence of Asymptomatic Mpox among Men Who Have Sex with Men, Japan, January–March 2023

CITE Title : Prevalence of Asymptomatic Mpox among Men Who Have Sex with Men, Japan, January–March 2023 Personal Author(s) : Mizushima, Daisuke;Shintani, Yui;Takano, Misao;Shiojiri, Daisuke;Ando, Naokatsu;Aoki, Takahiro;Watanabe, Koji;Nakamoto, Takato;Gatanaga, Hiroyuki;Oka, Shinichi; Published Date : 9 2023 Source : Emerg Infect Dis. 2023; 29(9):1872-1876 URL : https://stacks.cdc.gov/view/cdc/133594 Mizushima, Daisuke et al. (2023). Prevalence of Asymptomatic Mpox among Men Who Have Sex with Men, Japan, January–March 2023. 29(9). Mizushima, Daisuke et al. "Prevalence of Asymptomatic Mpox among Men Who Have Sex with Men, Japan, January–March 2023" 29, no. 9 (2023) Mizushima, Daisuke et al. "Prevalence of Asymptomatic Mpox among Men Who Have Sex with Men, Japan, January–March 2023" vol. 29, no. 9, 2023 Export RIS Citation Information.

:

Mizushima, Daisuke ;

Shintani, Yui

9 2023 | Emerg Infect Dis. 2023; 29(9):1872-1876

:

We prospectively assessed asymptomatic monkeypox virus infections among men who have sex with men in Tokyo, Japan, during the initial phase of the mpo...
Proteomic biomarker analysis of serum from Japanese field mice (Apodemus speciosus) collected within the Fukushima difficult to return zone

CITE Title : Proteomic biomarker analysis of serum from Japanese field mice (Apodemus speciosus) collected within the Fukushima difficult to return zone Personal Author(s) : Sproull, Mary;Hayes, Joshua;Ishiniwa, Hiroko;Nanba, Kenji;Shankavaram, Uma;Camphausen, Kevin;Johnson, Thomas E.; Published Date : 12 01 2021;12-01-; Source : Health Phys. 121(6):564-573 URL : https://stacks.cdc.gov/view/cdc/114848 Sproull, Mary et al. (2021). Proteomic biomarker analysis of serum from Japanese field mice (Apodemus speciosus) collected within the Fukushima difficult to return zone. 121(6). Sproull, Mary et al. "Proteomic biomarker analysis of serum from Japanese field mice (Apodemus speciosus) collected within the Fukushima difficult to return zone" 121, no. 6 (2021) Sproull, Mary et al. "Proteomic biomarker analysis of serum from Japanese field mice (Apodemus speciosus) collected within the Fukushima difficult to return zone" vol. 121, no. 6, 2021 Export RIS Citation Information.

:

Sproull, Mary ;

Hayes, Joshua

12 01 2021 | Health Phys. 121(6):564-573

:

Purpose:The environmental impact of the Fukushima Daiichi nuclear power plant accident is a source of ongoing concern as there is uncertainty regardin...
SARS-CoV-2 Incubation Period during Omicron BA.5–Dominant Period, Japan

CITE Title : SARS-CoV-2 Incubation Period during Omicron BA.5–Dominant Period, Japan Personal Author(s) : Cheng, Hao-Yuan;Akhmetzhanov, Andrei R.;Dushoff, Jonathan; Published Date : 1 2024 Source : Emerg Infect Dis. 2024; 30(1):206-207 URL : https://stacks.cdc.gov/view/cdc/140562 Cheng, Hao-Yuan et al. (2024). SARS-CoV-2 Incubation Period during Omicron BA.5–Dominant Period, Japan. 30(1). Cheng, Hao-Yuan and Akhmetzhanov, Andrei R. and Dushoff, Jonathan "SARS-CoV-2 Incubation Period during Omicron BA.5–Dominant Period, Japan" 30, no. 1 (2024) Cheng, Hao-Yuan et al. "SARS-CoV-2 Incubation Period during Omicron BA.5–Dominant Period, Japan" vol. 30, no. 1, 2024 Export RIS Citation Information.

:

Cheng, Hao-Yuan ;

Akhmetzhanov, Andrei R.

1 2024 | Emerg Infect Dis. 2024; 30(1):206-207

No Description
Compliance Trajectory and Patterns of COVID-19 Preventive Measures, Japan, 2020–2022

CITE Title : Compliance Trajectory and Patterns of COVID-19 Preventive Measures, Japan, 2020–2022 Personal Author(s) : Kusama, Taro;Takeuchi, Kenji;Tamada, Yudai;Kiuchi, Sakura;Osaka, Ken;Tabuchi, Takahiro; Published Date : 9 2023 Source : Emerg Infect Dis. 2023; 29(9):1747-1756 URL : https://stacks.cdc.gov/view/cdc/133562 Kusama, Taro et al. (2023). Compliance Trajectory and Patterns of COVID-19 Preventive Measures, Japan, 2020–2022. 29(9). Kusama, Taro et al. "Compliance Trajectory and Patterns of COVID-19 Preventive Measures, Japan, 2020–2022" 29, no. 9 (2023) Kusama, Taro et al. "Compliance Trajectory and Patterns of COVID-19 Preventive Measures, Japan, 2020–2022" vol. 29, no. 9, 2023 Export RIS Citation Information.

:

Kusama, Taro ;

Takeuchi, Kenji

9 2023 | Emerg Infect Dis. 2023; 29(9):1747-1756

:

COVID-19 remains a global health threat. Compliance with nonpharmaceutical interventions is essential because of limited effectiveness of COVID-19 vac...
Infection-Induced SARS-CoV-2 Seroprevalence among Blood Donors, Japan, 2022

CITE Title : Infection-Induced SARS-CoV-2 Seroprevalence among Blood Donors, Japan, 2022 Personal Author(s) : Kinoshita, Ryo;Arashiro, Takeshi;Kitamura, Noriko;Arai, Satoru;Takahashi, Koki;Suzuki, Tadaki;Suzuki, Motoi;Yoneoka, Daisuke; Published Date : 9 2023 Source : Emerg Infect Dis. 2023; 29(9):1868-1871 URL : https://stacks.cdc.gov/view/cdc/133580 Kinoshita, Ryo et al. (2023). Infection-Induced SARS-CoV-2 Seroprevalence among Blood Donors, Japan, 2022. 29(9). Kinoshita, Ryo et al. "Infection-Induced SARS-CoV-2 Seroprevalence among Blood Donors, Japan, 2022" 29, no. 9 (2023) Kinoshita, Ryo et al. "Infection-Induced SARS-CoV-2 Seroprevalence among Blood Donors, Japan, 2022" vol. 29, no. 9, 2023 Export RIS Citation Information.

:

Kinoshita, Ryo ;

Arashiro, Takeshi

9 2023 | Emerg Infect Dis. 2023; 29(9):1868-1871

:

A nationwide survey of SARS-CoV-2 antinucleocapsid seroprevalence among blood donors in Japan revealed that, as of November 2022, infection-induced se...
Sporadic Occurrence of Ensitrelvir-Resistant SARS-CoV-2, Japan

CITE Title : Sporadic Occurrence of Ensitrelvir-Resistant SARS-CoV-2, Japan Personal Author(s) : Doi, Akihiro;Ota, Masayuki;Saito, Masumichi;Matsuyama, Shutoku; Published Date : 6 2024 Source : Emerg Infect Dis. 2024; 30(6):1289-1291 URL : https://stacks.cdc.gov/view/cdc/156994 Doi, Akihiro et al. (2024). Sporadic Occurrence of Ensitrelvir-Resistant SARS-CoV-2, Japan. 30(6). Doi, Akihiro et al. "Sporadic Occurrence of Ensitrelvir-Resistant SARS-CoV-2, Japan" 30, no. 6 (2024) Doi, Akihiro et al. "Sporadic Occurrence of Ensitrelvir-Resistant SARS-CoV-2, Japan" vol. 30, no. 6, 2024 Export RIS Citation Information.

:

Doi, Akihiro ;

Ota, Masayuki

6 2024 | Emerg Infect Dis. 2024; 30(6):1289-1291

:

Using the GISAID EpiCoV database, we identified 256 COVID-19 patients in Japan during March 31-December 31, 2023, who had mutations in the SARS-CoV-2 ...
Infection- and Vaccine-Induced SARS-CoV-2 Seroprevalence, Japan, 2023

CITE Title : Infection- and Vaccine-Induced SARS-CoV-2 Seroprevalence, Japan, 2023 Personal Author(s) : Kinoshita, Ryo;Miyamoto, Sho;Sakuraba, Shoko;Sugihara, Jun;Suzuki, Motoi;Suzuki, Tadaki;Yoneoka, Daisuke; Published Date : 6 2024 Source : Emerg Infect Dis. 2024; 30(6):1267-1270 URL : https://stacks.cdc.gov/view/cdc/156981 Kinoshita, Ryo et al. (2024). Infection- and Vaccine-Induced SARS-CoV-2 Seroprevalence, Japan, 2023. 30(6). Kinoshita, Ryo et al. "Infection- and Vaccine-Induced SARS-CoV-2 Seroprevalence, Japan, 2023" 30, no. 6 (2024) Kinoshita, Ryo et al. "Infection- and Vaccine-Induced SARS-CoV-2 Seroprevalence, Japan, 2023" vol. 30, no. 6, 2024 Export RIS Citation Information.

:

Kinoshita, Ryo ;

Miyamoto, Sho

6 2024 | Emerg Infect Dis. 2024; 30(6):1267-1270

:

We assessed SARS-CoV-2 seroprevalence in Japan during July-August 2023, with a focus on 2 key age groups, 0-15 and >80 years. We estimated overall ser...
Vaccine Effectiveness against SARS-CoV-2 among Household Contacts during Omicron BA.2–Dominant Period, Japan

CITE Title : Vaccine Effectiveness against SARS-CoV-2 among Household Contacts during Omicron BA.2–Dominant Period, Japan Personal Author(s) : Ogata, Tsuyoshi;Tanaka, Hideo;Kon, Akemi;Sakaibori, Noriko;Tanaka, Emiko; Published Date : 7-2024 Source : Emerg Infect Dis. 2024; 30(7):1430-1433 URL : https://stacks.cdc.gov/view/cdc/158091 Ogata, Tsuyoshi et al. (2024). Vaccine Effectiveness against SARS-CoV-2 among Household Contacts during Omicron BA.2–Dominant Period, Japan. 30(7). Ogata, Tsuyoshi et al. "Vaccine Effectiveness against SARS-CoV-2 among Household Contacts during Omicron BA.2–Dominant Period, Japan" 30, no. 7 (2024) Ogata, Tsuyoshi et al. "Vaccine Effectiveness against SARS-CoV-2 among Household Contacts during Omicron BA.2–Dominant Period, Japan" vol. 30, no. 7, 2024 Export RIS Citation Information.

:

Ogata, Tsuyoshi ;

Tanaka, Hideo

7-2024 | Emerg Infect Dis. 2024; 30(7):1430-1433

:

We calculated attack rates for household contacts of COVID-19 patients during the SARS-CoV-2 Omicron BA.2-dominant period in Japan. Attack rates among...
Analysis of Suspected Measles Cases with Discrepant Measles-Specific IgM and rRT-PCR Test Results, Japan

CITE Title : Analysis of Suspected Measles Cases with Discrepant Measles-Specific IgM and rRT-PCR Test Results, Japan Personal Author(s) : Kuba, Yumani;Nidaira, Minoru;Maeshiro, Noriyuki;Komase, Katsuhiro;Kamiya, Hajime;Kyan, Hisako; Published Date : 5 2024 Source : Emerg Infect Dis. 2024; 30(5):926-933 URL : https://stacks.cdc.gov/view/cdc/154883 Kuba, Yumani et al. (2024). Analysis of Suspected Measles Cases with Discrepant Measles-Specific IgM and rRT-PCR Test Results, Japan. 30(5). Kuba, Yumani et al. "Analysis of Suspected Measles Cases with Discrepant Measles-Specific IgM and rRT-PCR Test Results, Japan" 30, no. 5 (2024) Kuba, Yumani et al. "Analysis of Suspected Measles Cases with Discrepant Measles-Specific IgM and rRT-PCR Test Results, Japan" vol. 30, no. 5, 2024 Export RIS Citation Information.

:

Kuba, Yumani ;

Nidaira, Minoru

5 2024 | Emerg Infect Dis. 2024; 30(5):926-933

:

We investigated clinically suspected measles cases that had discrepant real-time reverse transcription PCR (rRT-PCR) and measles-specific IgM test res...
Sphingobium yanoikuyae Bacteremia, Japan

CITE Title : Sphingobium yanoikuyae Bacteremia, Japan Personal Author(s) : Miyamatsu, Yayoi;Tanizaki, Ryutaro;Yamada, Satoko; Published Date : 5-2024 Source : Emerg Infect Dis. 2024; 30(5):1060-1062 URL : https://stacks.cdc.gov/view/cdc/154869 Miyamatsu, Yayoi et al. (2024). Sphingobium yanoikuyae Bacteremia, Japan. 30(5). Miyamatsu, Yayoi and Tanizaki, Ryutaro and Yamada, Satoko "Sphingobium yanoikuyae Bacteremia, Japan" 30, no. 5 (2024) Miyamatsu, Yayoi et al. "Sphingobium yanoikuyae Bacteremia, Japan" vol. 30, no. 5, 2024 Export RIS Citation Information.

:

Miyamatsu, Yayoi ;

Tanizaki, Ryutaro

5-2024 | Emerg Infect Dis. 2024; 30(5):1060-1062

:

We report a case of Sphingobium yanoikuyae bacteremia in an 89-year-old patient in Japan. No standard antimicrobial regimen has been established for S...
Clostridium butyricum Bacteremia Associated with Probiotic Use, Japan

CITE Title : Clostridium butyricum Bacteremia Associated with Probiotic Use, Japan Personal Author(s) : Sada, Ryuichi Minoda;Matsuo, Hiroo;Motooka, Daisuke;Kutsuna, Satoshi;Hamaguchi, Shigeto;Yamamoto, Go;Ueda, Akiko; Published Date : 4 2024 Source : Emerg Infect Dis. 2024; 30(4):665-671 URL : https://stacks.cdc.gov/view/cdc/152973 Sada, Ryuichi Minoda et al. (2024). Clostridium butyricum Bacteremia Associated with Probiotic Use, Japan. 30(4). Sada, Ryuichi Minoda et al. "Clostridium butyricum Bacteremia Associated with Probiotic Use, Japan" 30, no. 4 (2024) Sada, Ryuichi Minoda et al. "Clostridium butyricum Bacteremia Associated with Probiotic Use, Japan" vol. 30, no. 4, 2024 Export RIS Citation Information.

:

Sada, Ryuichi Minoda ;

Matsuo, Hiroo

4 2024 | Emerg Infect Dis. 2024; 30(4):665-671

:

Clostridium butyricum, a probiotic commonly prescribed in Asia, most notably as MIYA-BM (Miyarisan Pharmaceutical Co., Ltd.; https://www.miyarisan.com...
Prevalence of and Risk Factors for Post–COVID-19 Condition during Omicron BA.5–Dominant Wave, Japan

CITE Title : Prevalence of and Risk Factors for Post–COVID-19 Condition during Omicron BA.5–Dominant Wave, Japan Personal Author(s) : Iba, Arisa;Hosozawa, Mariko;Hori, Miyuki;Muto, Yoko;Muraki, Isao;Masuda, Rie;Tamiya, Nanako;Iso, Hiroyasu; Published Date : 7 2024;7-2024; Source : Emerg Infect Dis. 2024; 30(7):1380-1389 URL : https://stacks.cdc.gov/view/cdc/158102 Iba, Arisa et al. (2024). Prevalence of and Risk Factors for Post–COVID-19 Condition during Omicron BA.5–Dominant Wave, Japan. 30(7). Iba, Arisa et al. "Prevalence of and Risk Factors for Post–COVID-19 Condition during Omicron BA.5–Dominant Wave, Japan" 30, no. 7 (2024) Iba, Arisa et al. "Prevalence of and Risk Factors for Post–COVID-19 Condition during Omicron BA.5–Dominant Wave, Japan" vol. 30, no. 7, 2024 Export RIS Citation Information.

:

Iba, Arisa ;

Hosozawa, Mariko

7 2024 | Emerg Infect Dis. 2024; 30(7):1380-1389

:

The increased risk for post-COVID-19 condition after the Omicron-dominant wave remains unclear. This population-based study included 25,911 persons in...